Sequoia Pollen Allergy: The Redwood's Hidden Role in California Cedar Fever
Sequoia pollen allergy is caused by Cupressaceae family pollen from coast redwood and giant sequoia trees, which share greater than 90 percent sequence identity with the allergens driving cedar fever in Texas and Arizona. Sensitized patients in California and the Pacific Northwest may react to sequoia pollen from February through April without ever realizing it belongs to the same allergen family as mountain cedar. Sublingual immunotherapy targeting Cupressaceae pollen can address cross-reactive sequoia sensitization.
Free Β· 5 min Β· Insurance accepted
Key facts
Cupressaceae Group 1 allergens (Cup a 1, Jun a 1, Cry j 1, Cha o 1) share greater than 90% amino acid sequence identity β providing near-complete cross-reactivity between sequoia and cedar species.
Matricardi et al., EAACI Molecular Allergology User's Guide, 2016
No allergens specific to Sequoia have been formally listed by WHO/IUIS β 0 species-specific designations exist β but Cupressaceae family cross-reactivity exceeds 90% at Group 1.
Coast redwood and giant sequoia shed pollen from small male cones each February through April β approximately 25β30 micrometer diameter grains that travel significant distances.
California patients sensitized to Arizona cypress (Hesperocyparis arizonica) are effectively pre-sensitized to sequoia pollen through shared >90% Cupressaceae Group 1 allergen identity.
Cupressaceae pollen ranks among the most important winter-to-spring sensitization sources in California, contributing to regional allergen burden across the state's approximately 39 million residents.
What Is Sequoia Pollen Allergy?
Sequoia pollen allergy is a Cupressaceae family pollen allergy caused by windborne pollen from Sequoia sempervirens (coast redwood) and Sequoiadendron giganteum (giant sequoia) β two of the world's largest and longest-lived trees.
While these trees are celebrated for their extraordinary size, they are equally notable as members of the cypress family, sharing the same Group 1 pectate lyase allergen architecture (Cup a 1 homologs) that drives cedar fever in Texas and hinoki cypress allergy in Japan. No allergens specific to Sequoia have been formally listed by the WHO/IUIS, but Cupressaceae cross-reactivity exceeds 90% sequence identity among Group 1 allergens β meaning patients sensitized to Arizona cypress, mountain cedar, or Japanese cedar are almost certainly cross-reactive with sequoia pollen proteins. Coast redwood is native to the foggy coastal strip of California and Oregon; giant sequoia is native to the Sierra Nevada western slopes.
Both species are also widely planted as ornamentals in warm US cities from Los Angeles to the Gulf Coast. In California, Cupressaceae pollen β of which sequoia is a contributing member β ranks among the most important winter-to-spring sensitization sources. Sequoia pollen grains are small (approximately 25 to 30 micrometers), easily aerosolized, and capable of traveling significant distances from source trees.
Symptoms of Sequoia Pollen Allergy
Recognizing symptoms early helps you get the right treatment faster.
Rhinorrhea (runny nose)
moderateWatery to mucoid nasal discharge is one of the most consistent symptoms during Cupressaceae pollen season, often beginning within minutes of outdoor exposure.
Nasal congestion
moderateSignificant nasal obstruction that can disrupt sleep and impair daytime function, particularly during high-pollen mornings in California.
Sneezing
mildRepetitive sneezing fits triggered by airborne Cupressaceae pollen are a hallmark symptom, especially on dry, windy days with high pollen dispersal.
Allergic conjunctivitis
moderateItchy, watery, red eyes from Cupressaceae pollen deposition on the ocular surface; can be severe enough to impair driving safety.
Itchy palate and throat
mildPruritis of the soft palate and posterior pharynx β often described as an internal itch β is characteristic of airborne pollen exposure.
Allergic bronchospasm
severeIn asthmatic patients, Cupressaceae pollen can trigger wheezing and chest tightness. Seek medical care if breathing difficulty develops or a rescue inhaler is needed more than twice weekly.
Fatigue and malaise
moderateModerate to severe pollinosis commonly produces systemic fatigue, cognitive fog, and general malaise that impairs work and school performance during the season.
When to see a doctor
Sequoia pollen allergy symptoms are clinically indistinguishable from other Cupressaceae pollen allergies because the cross-reactive allergen proteins are structurally near-identical. Symptoms range from mild rhinitis to severe rhinoconjunctivitis resembling Texas cedar fever, depending on the individual's sensitization level and cumulative pollen exposure. California residents near redwood groves or heavily planted urban sequoia trees can experience sustained daily symptoms throughout the February to April window. In pollen-allergic asthma patients, Cupressaceae pollen exposure can precipitate bronchospasm and wheezing β asthma management during the sequoia season should be proactively intensified. The symptom threshold for Cupressaceae pollen is relatively low, meaning even moderate pollen counts can trigger symptoms in highly sensitized individuals. Board-certified allergists in California routinely test for Cupressaceae sensitization using Arizona cypress or mountain cedar extract because these are the best-characterized family representatives; a positive result to either effectively predicts cross-reactive sequoia sensitivity. Severe systemic reactions to pollen alone are not typical, but patients with pollen-triggered asthma should have an asthma action plan in place for high-pollen days.
Cupressaceae Pollen and Asthma in California
Cupressaceae pollen is an established asthma trigger in California, where the combined Cupressaceae season (Arizona cypress, sequoia, cedar, juniper) extends from December through April. Studies from Spanish and Italian populations β where Cupressaceae allergy is similarly prevalent β document that Cupressus pollen is associated with asthma exacerbation hospitalizations at pollen counts exceeding threshold levels. California asthma patients sensitized to Cupressaceae should maintain their controller medication throughout the winter-spring window rather than treating it as a low-risk period between grass and ragweed seasons. Sequoia's contribution to the California Cupressaceae pollen burden is particularly relevant near coastal redwood forests and in cities with extensive ornamental redwood plantings. Asthmatic patients planning outdoor activities in redwood parks during February through April should discuss pre-treatment strategies with their physician. The Cupressaceae Group 1 pectate lyase proteins are potent bronchial sensitizers, and the year-over-year accumulation of sensitization with repeated California season exposures can shift rhinitis-predominant disease toward asthma over time.
Complications of Sequoia Pollen Allergy
Untreated or inadequately treated Cupressaceae pollen allergy β including sequoia sensitization β carries several clinically significant complication risks over the multi-month California winter-spring season. Prolonged nasal inflammation increases the risk of sinusitis, as swollen nasal passages impair sinus ostia drainage and create conditions favorable for bacterial or viral superinfection. Eustachian tube dysfunction from sustained nasal congestion can cause middle ear pressure changes and transient conductive hearing loss. In asthmatic patients, failure to aggressively manage Cupressaceae pollen exposure during the February to April window contributes to progressive bronchial remodeling from repeated inflammation cycles. Sleep disruption from nocturnal nasal congestion has compounding quality-of-life consequences over a prolonged seasonal exposure period.
Acute bacterial sinusitis
Prolonged nasal congestion from Cupressaceae pollen exposure impairs sinus drainage, increasing the risk of secondary bacterial sinusitis requiring antibiotic treatment.
Asthma exacerbation
Cupressaceae pollen is a documented asthma trigger; uncontrolled California pollinosis season can lead to asthma hospitalizations in sensitized patients.
Sleep-disordered breathing
Nasal obstruction during the extended winter-spring pollen season disrupts sleep quality, worsening daytime fatigue and cognitive function.
Sensitization escalation
Unmanaged yearly Cupressaceae pollen exposure can progressively worsen sensitization over time, shifting from mild rhinitis to moderate or severe disease.
What Causes Sequoia Pollen Allergy?
Sequoia pollen allergy is driven by the Cupressaceae family allergen architecture rather than sequoia-specific proteins alone. Cupressaceae Group 1 allergens β pectate lyases designated Cup a 1 (Arizona cypress), Jun a 1 (mountain cedar), Cry j 1 (Japanese cedar), and Cha o 1 (hinoki cypress) β share greater than 90% amino acid sequence identity.
Coast redwood (California/Oregon fog belt)
Sequoia sempervirens
Giant sequoia (Sierra Nevada western slopes)
Sequoiadendron giganteum
Arizona cypress (cross-reactive Cupressaceae)
Hesperocyparis arizonica
Mountain cedar (Texas cedar fever, same family)
Juniperus ashei
Japanese cedar (cross-reactive globally)
Cryptomeria japonica
How it works
Sequoia pollen allergy operates through Type I IgE-mediated hypersensitivity. Cupressaceae pollen proteins β particularly Group 1 pectate lyases β bind to specific IgE antibodies on mast cells and basophils in sensitized individuals. On subsequent pollen exposure, cross-linking of membrane-bound IgE triggers degranulation and rapid release of histamine, tryptase, leukotrienes, and prostaglandins. This produces the classic immediate-phase allergic response: nasal congestion, rhinorrhea, sneezing, conjunctival injection, and β in susceptible individuals β bronchospasm. The late-phase response follows 4 to 8 hours later as recruited eosinophils and T cells sustain inflammatory signaling, contributing to the prolonged daily symptoms of cedar-fever-like syndrome.
This exceptional conservation means IgE antibodies raised against any one of these proteins will bind with high affinity to the homologous proteins in all other Cupressaceae species, including sequoia. Sequoia trees produce pollen from small male cones that open each February through April in California's coastal regions.
A single mature redwood or sequoia specimen can produce enormous quantities of pollen, and large redwood groves in coastal California and the Sierra Nevada represent significant seasonal pollen sources. In central and southern California, Arizona cypress (Hesperocyparis arizonica) dominates winter-to-spring Cupressaceae pollen counts, and patients sensitized to Arizona cypress are essentially pre-sensitized to any other Cupressaceae pollen they subsequently encounter β including sequoia.
Pollen monitoring stations in California regularly record Cupressaceae pollen from February through April, with contributions from multiple family members including sequoia in coastal and foothill zones.
Risk factors to watch for
Residence in California or Pacific Northwest
Living in coastal California, the Sierra Nevada foothills, or the Oregon coast places patients in the primary natural range of both coast redwood and giant sequoia pollen release zones.
Prior Cupressaceae sensitization
Patients sensitized to mountain cedar (Texas), Arizona cypress, or Japanese cedar carry IgE antibodies that cross-react with greater than 90% efficiency with sequoia Group 1 pectate lyase proteins.
Atopic background
Individuals with a personal or family history of allergic rhinitis, asthma, or eczema are at higher risk for sensitization to airborne pollen allergens including Cupressaceae.
Urban tree proximity
Both redwood and giant sequoia are widely planted in California urban and suburban landscapes, increasing pollen exposure for city residents beyond natural grove areas.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How Is Sequoia Pollen Allergy Diagnosed?
Sequoia pollen allergy is typically diagnosed through the Cupressaceae allergen family rather than sequoia-specific testing, because Arizona cypress and mountain cedar extracts are the best-standardized commercial representatives of the family. A board-certified allergist will perform skin prick testing using Arizona cypress (Hesperocyparis arizonica) or mountain cedar (Juniperus ashei) extract β a positive result confirms Cupressaceae family sensitization, which by virtue of greater than 90% Group 1 allergen sequence identity predicts cross-reactive sequoia sensitivity as well. Specific IgE blood testing using the ImmunoCAP system for Cupressaceae allergens provides quantitative sensitization data and can help distinguish primary sensitization from pan-allergen cross-reactivity. For patients who want to evaluate their full spring tree pollen sensitization profile, at-home allergy testing services such as Curex offer an alternative to in-clinic testing, with panels covering 40+ common allergens including tree and Cupressaceae pollens, results typically within 5 days, and insurance coverage often available. Component-resolved diagnostics (measuring specific Cup a 1 IgE) can help determine whether sensitization is to the major pectate lyase allergen or to minor pan-allergens (profilins, polcalcins), which influences immunotherapy target selection.
Skin Prick Test (Cupressaceae panel)
Extracts of Arizona cypress (Cup a 1) or mountain cedar (Jun a 1) are applied via lancet; wheal formation at 15 minutes confirms Cupressaceae family IgE sensitization, which predicts sequoia cross-reactivity.
Specific IgE Blood Test (ImmunoCAP)
A blood sample is tested for IgE to Cupressaceae allergens. Quantitative result aids in determining sensitization level and guides immunotherapy dosing decisions.
Component-Resolved Diagnostics (Cup a 1 IgE)
Measures IgE specifically to the Cup a 1 pectate lyase major allergen. Distinguishes primary Cupressaceae sensitization from pan-allergen cross-reactivity and predicts response to family-targeted immunotherapy.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
For patients with moderate to severe Cupressaceae pollen allergy β including cross-reactive sequoia sensitization β allergen immunotherapy is the only treatment that modifies the underlying immune response rather than just suppressing symptoms. Cupressaceae pollen is among the best-evidenced groups for immunotherapy efficacy, with multiple randomized controlled trials demonstrating 60 to 85% reduction in rhinitis symptom scores over a 3 to 5 year treatment course, with benefits persisting years after completion. The treatment uses standardized Arizona cypress or mountain cedar extract; because Group 1 allergens share greater than 90% sequence identity across the family, desensitization to one Cupressaceae member effectively addresses the entire Cupressaceae cross-reactive panel including sequoia pollen. Sublingual immunotherapy drops, offered by providers like Curex starting at $39/month, deliver custom-formulated allergen drops under the tongue at home, eliminating the weekly clinic requirement for allergy shots while maintaining equivalent clinical efficacy for the many patients who qualify. Unlike symptomatic medications that must be renewed every season indefinitely, immunotherapy provides durable disease modification β the immune tolerance built during treatment persists after the course is completed, sparing patients from years of continued pharmacotherapy. For California patients facing a December-to-April Cupressaceae season and its associated quality-of-life burden, this distinction is particularly meaningful.
Confirm Cupressaceae Sensitization
Skin prick testing or specific IgE for Arizona cypress or Jun a 1 confirms the Cupressaceae family sensitization that predicts sequoia cross-reactivity.
Select Immunotherapy Route
Choose between subcutaneous allergy shots (in-clinic) or sublingual SLIT drops (at-home) based on lifestyle, adherence, and provider availability.
Begin Buildup Phase
Gradual escalation of allergen dose over weeks to months trains the immune system toward tolerance, with decreasing symptom severity each subsequent pollen season.
Maintain for 3β5 Years
Sustaining immunotherapy for the full recommended course is essential for durable benefit that persists after treatment ends.
βClinical trials of Cupressaceae SLIT and SCIT show 60β85% reduction in seasonal symptom scores in the majority of treated patientsβ
Treat your Sequoia Pollen allergy at the source
See if at-home sublingual allergy drops fit your allergies β a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Sequoia Pollen Allergy in California
For California residents, living with Cupressaceae pollen allergy β including cross-reactive sequoia sensitivity β means navigating one of the longest consecutive pollen seasons in the country. The December-to-April window spans winter holiday travel plans, early new year return to school and work, and the entire spring build-up. Many California patients with Cupressaceae allergy previously thought they had chronic year-round nasal disease rather than seasonal allergy, because the season is so long relative to the allergy-free summer and fall period. Understanding the seasonal calendar β and recognizing that February-to-April symptoms near redwood areas are part of the same allergen family as 'cedar fever' β is a pivotal reframe that opens the door to targeted treatment rather than generic antihistamine cycling.
California pollen calendar awareness
Mark your calendar for Cupressaceae season starting in January and extending through April. Proactive medication start and indoor air quality measures set up for a less symptomatic season rather than reactive scrambling once symptoms are already established.
Redwood park planning
If you enjoy hiking in redwood parks or forests, schedule those trips for summer and fall when sequoia pollen season is over. February through April visits to coastal redwood parks during peak pollen release can produce intense sustained exposure.
Connecting cedar fever to California allergy
If you have moved from Texas to California and had cedar fever, know that your cedar sensitization means you already carry the IgE antibodies to react to California's sequoia and Arizona cypress pollen. Talk to a California allergist about extending your treatment plan into the winter-spring season.
Seasonal Patterns
December - February
medium intensity
February - April
high intensity
Prevention Tips
Start medications pre-season
Begin intranasal corticosteroids and antihistamines one to two weeks before your typical symptom onset β for California Cupressaceae allergy, this means starting in January.
Monitor pollen counts daily
Use the AAAAI national pollen network or local California Air Quality Management District pollen alerts to anticipate high-count days and adjust outdoor plans.
Use HEPA filtration indoors
HEPA air purifiers in bedroom and main living areas substantially reduce indoor pollen load, improving overnight sleep quality during the extended California season.
Shower and change after outdoor time
Pollen deposited on hair, skin, and clothing during outdoor activity is transferred to bedding and indoor surfaces; showering and changing after returning home reduces overnight exposure.
Wear wraparound sunglasses outdoors
Wraparound or fitted sunglasses provide a physical barrier to pollen deposition on the ocular surface, reducing conjunctivitis severity during outdoor activity.
Prognosis for Sequoia Pollen Allergy
The prognosis for Cupressaceae pollen allergy including sequoia cross-reactive sensitization is excellent with appropriate management. As a seasonal allergen with a defined February-to-April peak, symptoms are predictable and manageable with proactive pharmacotherapy. Immunotherapy targeting the Cupressaceae family offers durable disease modification with documented 60 to 85% long-term symptom reduction. Without treatment, progressive sensitization can occur over years of California residency, with mild initial rhinitis potentially evolving toward more severe pollinosis or pollen-triggered asthma. Early diagnosis and intervention β particularly immunotherapy in the first years of significant symptom burden β provides the best long-term outcome. California patients have access to outstanding allergist density and well-characterized Cupressaceae immunotherapy options, making this one of the most manageable aeroallergen conditions in the US.
Key takeaways
Sequoia pollen cross-reacts with all Cupressaceae allergens (cedar, cypress, hinoki) via >90% shared Group 1 pectate lyase identity
California Cupressaceae season December to April is one of the longest consecutive pollen seasons in the US β proactive treatment is essential
Immunotherapy targeting the Cupressaceae family produces durable 60β85% symptom reduction, including sequoia cross-reactive sensitization
No food cross-reactivity exists for Cupressaceae allergens β dietary modification is not needed
Sequoia pollen allergy is practically the same allergy as mountain cedar or Arizona cypress β the same pectate lyase allergen family with over 90% sequence identity. A California patient with cedar fever visiting Texas is already sensitized to sequoia at home, just under a different family member's name.
Frequently Asked Questions
Sequoia pollen allergy and cedar fever are caused by the same allergen family β Cupressaceae Group 1 pectate lyases β and patients sensitized to one are almost certainly cross-reactive with the other. Cedar fever refers specifically to Texas mountain cedar (Juniperus ashei, Jun a 1 allergen) seasons in December through March; sequoia allergy occurs in California from February through April. The two conditions share greater than 90% molecular allergen identity. If you had cedar fever in Texas and move to California, your cedar sensitization makes you pre-sensitized to Arizona cypress and sequoia before your first California spring season. Immunotherapy targeting one Cupressaceae member addresses the entire cross-reactive family.
Yes β sequoia pollen grains are approximately 25 to 30 micrometers in size, placing them in the range of effective long-distance wind transport. Cupressaceae pollen grains are well-documented as significant long-range aeroallergens; Arizona cypress pollen has been detected hundreds of kilometers from source trees during high-wind events in Spain. California pollen monitoring stations routinely record Cupressaceae contributions including sequoia pollen during February through April. However, highest exposure occurs within and immediately adjacent to redwood groves and urban sequoia plantings. Patients living near coastal redwood parks or in neighborhoods with dense ornamental redwood plantings face higher cumulative seasonal doses.
Because sequoia pollen allergens have not been independently characterized by WHO/IUIS, there is theoretically a possibility of sequoia-specific IgE reactivity not reflected by standard cedar or cypress testing β but this would be unusual. In practice, allergy testing using Cupressaceae family extracts (Arizona cypress, mountain cedar) reliably identifies clinically relevant sensitization to the family as a whole, including sequoia. If you have spring California pollen symptoms but test negative to standard Cupressaceae panels, a board-certified allergist should evaluate for other spring tree pollens (birch, oak, ash) and consider whether your symptom calendar aligns specifically with the Cupressaceae pollen window.
In coastal California and the Bay Area, sequoia pollen peaks in February and March. In the Sierra Nevada foothills and higher elevations, peak pollen is delayed until March through April depending on spring temperatures and snowpack. In southern California and warmer urban areas with ornamental plantings, pollen can begin in late January. The single worst days are typically dry, warm, and slightly windy β conditions that maximize pollen release and dispersal from male cones. Fog and overcast conditions typical of the California coast in winter partially suppress airborne pollen counts, providing some natural relief on marine-layer days.
Yes β sublingual immunotherapy (SLIT) drops targeting Cupressaceae allergens are among the most clinically studied SLIT indications, with multiple randomized controlled trials demonstrating 60 to 80% reduction in seasonal symptom scores over a 3 to 5 year treatment course. Because sequoia pollen shares greater than 90% sequence identity with the characterized Cupressaceae allergens used in SLIT formulations, patients with sequoia cross-reactive sensitization benefit from the same treatment that targets Arizona cypress or cedar. The advantage of SLIT drops over allergy shots is that they can be taken at home, eliminating weekly clinic visits β important for patients navigating California's long December-to-April Cupressaceae season.
Mature sequoia and redwood trees can produce very large quantities of pollen. Cupressaceae trees in general are prolific pollen producers β research documents approximately 400,000 pollen grains per male cone and an estimated 276 billion grains per mature tree per season. Coast redwoods and giant sequoias produce pollen from numerous small male cones distributed throughout the canopy. However, because the individual pollen grains are relatively small (25 to 30 micrometers) compared to some tree pollens, they are efficiently aerosolized and dispersed widely. In redwood grove settings during peak pollen release, visible yellow-green pollen clouds can be observed drifting through the canopy β a striking visual indicator of the pollen load.
Yes β Cupressaceae pollen, including sequoia, can trigger asthmatic episodes in sensitized patients with pre-existing airway hyperreactivity. The Group 1 pectate lyase proteins are potent bronchial sensitizers, and pollen exposure studies confirm bronchospasm triggering above threshold concentrations. In California, the extended winter-spring Cupressaceae season (December to April) means asthmatic patients face a prolonged period of airway challenge. Unlike summer-autumn ragweed seasons in the eastern US, California's Cupressaceae season occurs during cooler months when cold air itself can compound airway reactivity. Asthmatic patients with Cupressaceae sensitization should discuss a proactive asthma action plan for the California winter-spring season with their pulmonologist or allergist.
Sequoia and Japanese cedar (Cryptomeria japonica) allergy are clinically very similar because both are Cupressaceae family allergens with Group 1 pectate lyase proteins sharing over 90% amino acid sequence identity. The primary differences are geographic and exposure-based: Japanese cedar (Sugi) allergy is one of Japan's most significant public health allergen problems, affecting 25 to 40% of the Japanese population during the February through April season. In the US, sequoia is the regionally important Cupressaceae representative for California and Pacific Northwest patients. Immunotherapy programs targeting Japanese cedar (Cry j 1) would theoretically cross-protect against sequoia exposure, and vice versa β though in US clinical practice, Arizona cypress or mountain cedar extract is used as the Cupressaceae family representative.
Yes, a consultation with a board-certified allergist is advisable if you experience consistent nasal, eye, or respiratory symptoms during February through April in California, particularly if you spend time near redwood forests, parks, or neighborhoods with ornamental sequoia plantings. An allergist can perform Cupressaceae family skin prick testing or specific IgE measurement to confirm your sensitization, evaluate the full spring tree pollen picture (oak, ash, birch, sequoia), and recommend a management plan including pharmacotherapy and potential immunotherapy candidacy. Early evaluation and intervention β before progressive sensitization develops β provides better long-term outcomes than waiting for symptoms to become severe.
Giant sequoias (Sequoiadendron giganteum) are native only to the western slopes of California's Sierra Nevada, though they are widely planted as ornamentals in warm-climate cities across the US, Europe, and Australia. Coast redwoods (Sequoia sempervirens) are native to the coastal fog belt from southwestern Oregon to central California. Outside their native ranges, both species are planted in suitable climates β including parts of the Pacific Northwest, mild mid-Atlantic cities, and southern Europe β where they can contribute to local Cupressaceae pollen loads. In regions where sequoias are ornamentally planted, patients sensitized to Arizona cypress or cedar should be aware that the ornamental redwoods in their neighborhood may contribute to their spring symptom burden during February through April.
Medical References
- [1]Ito K, Sato S, Nishimura T, et al. Comprehensive analysis of cross-reactive allergens in Japanese cedar and cypress pollens. Clin Exp Allergy. 2013;43(8):889β897.
- [2]Bousquet J, Knani J, Hejjaoui A, et al. Heterogeneity of atopy. I. Clinical and immunologic characteristics of patients allergic to cypress pollen. Allergy. 1993;48(3):183β188.
- [3]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy. 2007;62(9):976β990.
- [4]Charpin D, Pichot C, Belmonte J, et al. Cypress pollinosis: from tree to clinic. Clin Rev Allergy Immunol. 2019;56(2):174β195.
- [5]American Academy of Allergy, Asthma & Immunology (AAAAI). Pollen Library β Cupressaceae/Juniper/Cedar.
- [6]RodrΓguez R, Villalba M, Batanero E, et al. Emerging pollen allergens. Biomed Pharmacother. 2007;61(2β3):86β96.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Sequoia Pollen allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
